Pharmaceutical Executive
October 15, 2008
News Analysis
0
0
Analysts report that Big Pharma isn't being hit that hard by the credit crunch due to the large amount of cash many companies have in their coffers for mergers and acquisitions. However, smaller firms looking to be sold may have a hard time holding out for higher offers.
October 15, 2008
News Analysis
0
0
AZ interviewed physicians to determine why patients fail to take their medicine as prescribed. Unsurprisingly, affordability and patient apathy tied for top excuses. Pharm Exec talked to AZ to find out what the company is doing to boost compliance.
October 15, 2008
News Analysis
0
0
Specialty drug firm Norgine splits from the British pharma association due to a growing rift about pricing. A "war of the roses" is escalating between Big Pharma and smaller drug manufacturers; Norgine could be the first casualty.